Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    01038778
Previous Study | Return to List | Next Study

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by National Cancer Institute (NCI)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01038778
First received: December 18, 2009
Last updated: June 26, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)